Target intelligence / Profile preview

78 kDa glucose-regulated protein (GRP78)

Target
GRP78
Molecular classification
Molecular chaperone, Heat shock protein, Receptor, ATPase
01

Overview

78 kDa glucose-regulated protein (GRP78), also known as HSPA5 or BiP, is a member of the heat shock protein 70 (HSP70) family that primarily functions as a molecular chaperone in the endoplasmic reticulum (ER) [UniProt P11021]. While typically resident in the ER to assist in protein folding and the unfolded protein response (UPR), GRP78 translocates to the cell surface (csGRP78) under conditions of cellular stress, particularly in cancer cells. On the cell surface, it acts as a multifunctional receptor, activating pro-survival signaling pathways such as PI3K/Akt and MAPK, which promote tumor growth, metastasis, and chemoresistance. Because csGRP78 is preferentially expressed on malignant cells and not on most normal tissues, it has emerged as a promising therapeutic target for monoclonal antibodies, peptides, and drug conjugates. Therapeutic strategies include direct inhibition of its chaperone activity, induction of apoptosis, or utilizing it as a docking site for targeted delivery of cytotoxic agents.

Other names
Heat shock protein family A member 5HSPA5Binding immunoglobulin proteinBiPEndoplasmic reticulum lumenal Ca(2+)-binding protein grp78MIF2
02

Mechanism of action

Inhibition of chaperone activity, induction of apoptosis via the unfolded protein response, blockade of pro-survival signaling pathways (e.g., PI3K/Akt), and antibody-dependent cellular cytotoxicity (ADCC) targeting cell-surface localized protein.

03

Biological functions

Protein foldingEndoplasmic reticulum stress responseSignal transductionApoptosis regulationCell proliferationCalcium binding
04

Disease associations

CancerInfectionInflammationNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Potential off-target effects on essential ER-resident GRP78 functions in normal cellsSystemic toxicityImmune-mediated adverse eventsPotential for liver or pancreatic toxicity due to high basal ER chaperone requirements
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

Cell-surface GRP78 expressionAnti-GRP78 autoantibodiesHSPA5 mRNA levelsSerum GRP78 concentration

Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on 78 kDa glucose-regulated protein (GRP78).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 78 kDa glucose-regulated protein (GRP78).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call